Kato Yoshinori

• The Johns Hopkins University School of Medicine  Department of Radiology and Radiological Science   Adjunct Assistant Professor

• 2019 - 2022 血中エンドカンを利用したトリプルネガティブ乳がんの早期予後予測と臨床応用への展開
• 2011 - 2016 JHU ICMIC Program
• 2011 - 2016 Image-guided Combination Therapy: Noninvasive Assessment of Delivery And Response
• 2015 - 2016 Evaluation of stemness of human breast cancer cell line and its metastatic variants
• 2013 - 2015 Molecular imaging of exosomes in the lung metastatic niche
2010 - 2014 Novel Two-Component Delivery System Based on Her-2/neu Receptor Internalization Strategy
2010 - 2013 Noninvasive Imaging of Stem Cell Homing and Viability
2010 - 2013 A novel RNA helicase inhibitor to treat breast cancer
2012 - 2013 A Targeted Theranostic Nanoprobe For Real-Time Imaging of HSV1-TK in Brain Tumors
2009 - 2012 Activated nano-sized MR contrast agents for imaging of tumor proteolytic activity
2008 - 2012 Noninvasive Monitoring of In Vivo Drug Release
2010 - 2011 Microimaging of Nanocarrier Delivery in Brain Tumor Therapy
2010 - 2011 New Strategy for Cancer Therapy: Development of New Nanocarrier System
2007 - 2010 MR Pharmacoangiography - Vascular Modulation of Delivery
2008 - 2010 Targeted Imaging and Therapy of Breast Cancer Stem-like Cells
2008 - 2010 A lectin-contrast agent for multimodality molecular imaging of tumor angiogenesis
2007 - 2009 Visualization of In Vivo Release Characteristics and Intratumoral Distribution of Anticancer Drug-Loaded Nanoparticles
2007 - 2008 Molecular MR Imaging of Protease Activity in Breast Cancer with Activated Contrast Agents

• Yoko Kanada, Kentaro Daiki, Aya Nagata, Kanae Taruno, Takashi Kuwayama, Rikako Hashimoto, Hiroko Masuda, Sadako Akashi-Tanaka, Seigo Nakamura, Yoshinori Kato. Clinical significance of blood endocan level in breast cancer patients. The Showa University Journal of Medical Sciences. 2023. 35. 2. 98-102
• 小林 莉子, 川端 里奈, 纐纈 駿輔, 里 史明, 築地 信, 加藤 良規, 奥 輝明. ヒト乳がん細胞MDA-MB-231に対する抗体の作製と解析. 日本生化学会大会プログラム・講演要旨集. 2022. 95回. 3P-301
• Fumiaki Sato, Atsunobu Sagara, Kaede Tajima, Shotaro Miura, Kenjiro Inaba, Yusuke Ando, Teruaki Oku, Takashi Murakami, Yoshinori Kato, Tetsuro Yumoto. COL8A1 facilitates the growth of triple-negative breast cancer via FAK/Src activation. Breast cancer research and treatment. 2022
• 里 史明, 相良 篤信, 加藤 良規, 湯本 哲郎. COL8A1は、トリプルネガティブ乳がんの浸潤・転移を促進する. 日本結合組織学会学術大会プログラム・抄録集. 2021. 53回. 140-140
• 細江 智夫, 山本 弘, 酒井 寛泰, 五十嵐 信智, 今 理紗子, 加藤 良規, 岩崎 雄介, 武田 尚, 若菜 大悟, 吉澤 小百合[渡邉], et al. 4年制薬学教育における「学外体験学習(長期インターンシップ)」による社会人基礎力養成の試み. 日本薬学会年会要旨集. 2021. 141年会. 28P01-283

ｍore...

• 政所 和孝, 佐藤 健, 井上 裕香, 甲斐 友規, 松本 健次郎, 加藤 伸一, 里 史明, 湯本 哲郎, 千葉 義彦, 加藤 良規, et al. 接触皮膚炎時のELR+ケモカイン遺伝子発現亢進に対する皮膚掻破の役割. 日本薬学会年会要旨集. 2016. 136年会. 3. 184-184
• Sudath Hapuarachchige, Wenlian Zhu, Yoshinori Kato, Dmitri Artemov. Bioorthogonal, two-component drug delivery in HER2(+) breast cancer mouse models. CANCER RESEARCH. 2014. 74. 19
• Sudath Hapuarachchige, Yoshinori Kato, Dmitri Artemov. Cytotoxicity of two-component drug delivery systems targeting HER2(+) cancer cells. CANCER RESEARCH. 2013. 73. 8
• Kato Y, Pathak A.P. Combined contrast and therapeutic nanocarriers for oncologic MRI. Nanoimaging. 2011. 1-17
• Farhad Vesuna, Ala Lisok, Brian Kimble, John Domek, Yoshinori Kato, Dmitri Artemov, Jeanne Kowalski, Hetty Carraway, Paul van Diest, Venu Raman. Twist regulates estrogen receptor expression in breast cancer. CANCER RESEARCH. 2010. 70

ｍore...

• 分子病態薬理学III
  京都廣川書店 2017 ISBN:9784909197160
• Nanoimaging
  Pan Stanford Publishing Pte Ltd. 2011

• Bioorthogonal, two-component delivery systems based on antibody and drug-loaded nanocarriers for enhanced internalization of nanotherapeutics
  (2014)

• 1999 - 2002 Hoshi University School of Pharmacy and Pharmaceutical Sciences Dept. of Drug Delivery Research Ph.D.
• 1997 - 1999 Hoshi University School of Pharmacy and Pharmaceutical Sciences Department of Drug Delivery Research M.S.
• 1993 - 1997 Hoshi University School of Pharmacy and Pharmaceutical Sciences B.S.

• Ph.D. (Hoshi University)

• 2023/04 - 現在 Hoshi University Laboratory for Bioanalysis and Onco-Pharmaceutics Professor
• 2014/08 - 現在 The Johns Hopkins University School of Medicine Department of Radiology Adjunct Assistant Professor
• 2021/05 - 2023/03 Hoshi University Laboratory of Biopharmaceutics and Analytical Science Professor
• 2021/04 - 2021/04 Hoshi University Laboratory of Biofunctional Science Professor
• 2018/01 - 2021/03 Hoshi University School of Pharmacy and Pharmaceutical Sciences Laboratory of Biofunctional Science Associate Professor
2014/09 - 2017/12 Hoshi University School of Pharmacy and Pharmaceutical Sciences Life Science Tokyo Advanced Research Center (L-StaR) Associate Professor
2008/12 - 2014/07 The Johns Hopkins University Institute for NanoBioTechnology Affiliated faculty
2008/12 - 2014/07 The Johns Hopkins University School of Medicine Dept. of Oncology Assistant Professor
2008/12 - 2014/07 The Johns Hopkins University School of Medicine Dept. of Radiology, Div. of Cancer Imaging Research Assistant Professor
2006/06 - 2008/11 The Johns Hopkins University School of Medicine Dept. of Radiology, Div. of MR Research Research Associate

• 2023/04 - 現在 The Pharmaceutical Society of Japan Advisor of Farumashia
• 2020/04 - 2023/03 The Pharmaceutical Society of Japan Committee member of Farumashia
• 2015/05 - 2018/04 日本薬剤学会 「薬剤学」編集委員
• 2015/05 - 2018/04 APSTJ Editorial member of YAKUZAIGAKU

THE JAPANESE CANCER ASSOCIATION ,  Controlled Release Society ,  World Molecular Imaging Society ,  American Association for Cancer Research ,  THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM ,  International Society for Magnetic Resonance in Medicine ,  THE ACADEMY OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY, JAPAN ,  THE PHARMACEUTICAL SOCIETY OF JAPAN